title: Keeping sterile water for injection cold enough for reconstitution of azacitidine in isolators.
authors.affiliation: Oncopharma UnitPharmacy DepartmentLa Timone University Teaching HospitalAssistance Publique-Hôpitaux de MarseilleMarseilleFrance.
authors.forename: Amandine
authors.initials: A
authors.lastname: Savry
authors.forename: Florian
authors.initials: F
authors.lastname: Correard
authors.forename: Laurence Gauthier
authors.initials: LG
authors.lastname: Villano
authors.forename: Pascale
authors.initials: P
authors.lastname: Pisano
authors.forename: Bertrand
authors.initials: B
authors.lastname: Pourroy
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000737:chemistry*; D001374:Azacitidine / Q000737:chemistry*; D003080:Cold Temperature; D004339:Drug Compounding / Q000379:methods*; D004348:Drug Labeling; D004355:Drug Stability; D004356:Drug Storage; D004780:Environment, Controlled; D005612:Freeze Drying; D006801:Humans; D007267:Injections; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D013997:Time Factors; D014481:United States; D014867:Water / Q000737:chemistry*
chemical_list: D000964:Antimetabolites, Antineoplastic; D014867:Water; D001374:Azacitidine